FLFabricio Oliveira Lima

Fabricio Oliveira Lima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fabricio Oliveira Lima has a total of 273 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Intensive blood-pressure control for the prevention of major cardiovascular events in stroke patients: rationale and design of the OPTIMAL-STROKE trial

    by Gisele S Silva, M J Machline-Carrion, Karla Santo, João B Clares de Andrade, Eduardo Martins, Patrícia Guimarães, Frederico Monfardini, Josué Nieri, Silvia R L Assis, Sheila Cristina O Martins, et al.

    Background: In high cardiovascular risk populations without prior stroke, intensive blood pressure (BP) lowering confers greater reductions in cardiovascular events than standard targets. However, optimal BP targets in patients with ischaemic stroke (IS) or TIA remain uncertain. The primary objective of the OPTIMAL-STROKE trial is to assess whether an intensive systolic BP (SBP) target (SBP < 120 mmHg) reduces major cardiovascular events in patients with previous IS or TIA compared to a standard SBP target (SBP < 140 mmHg). Study design: OPTIMAL-STROKE is a multicentre, randomised, controlled, open-label clinical trial with blinded and independent assessment of clinical outcomes and intention-to-treat primary analysis. Patients with a history of IS or TIA and high BP (SBP of 130–180 mmHg), clinically stable for at least 48 h prior to trial inclusion, are centrally randomised with concealed allocation in a 1:1 ratio to either an intensive BP control strategy targeting a SBP < 120 mmHg or a standard control strategy targeting a SBP < 140 mmHg. A total of 495 primary outcome events, 4368 patients enrolled. Study endpoints: The primary outcome is the first occurrence of a composite outcome of major cardiovascular events (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, hospitalisation for unstable angina or hospitalisation for heart failure). Summary: OPTIMAL-STROKE will be the first adequately powered trial of intensive BP control in the prevention of major cardiovascular events in patients with a history of IS or TIA. Trial registration: The trial is registered at ClinicalTrials.gov (NCT04036409).


  • Open Access

    Age Is an Effect Modifier of Thrombectomy Benefit in a Socioeconomically Vulnerable Stroke Population

    by Fabricio O. Lima, Francisco José de A. Mont'ALverne, Letícia C. Rebello, Daniel G. Abud, Gisele S. Silva, Michel E. Frudit, Mário B. Wagner, Jamary Oliveira‐Filho, Diogo C. Haussen, David S. Liebeskind, et al.

    Objective: Randomized trials from high‐income countries have shown that endovascular treatment (EVT) yields similar benefits in elderly and non‐elderly patients with large vessel occlusion stroke (LVOS). However, evidence from low/middle‐income countries remains scarce. We aimed to assess the impact of age on outcomes and determine whether age modifies the effect of EVT under the resource‐limited conditions of a public healthcare system in a developing country. Methods: Pre‐specified subgroup analysis of the RESILIENT trial, a multicenter, randomized, controlled trial in Brazil comparing EVT versus medical treatment alone in anterior circulation LVOS. Patients were categorized as non‐elderly (p = 0.01). Age significantly modified the treatment effect of EVT. Non‐elderly patients derived substantial benefit from EVT (OR: 4.08; 95% CI: 1.71–9.76), whereas the benefit was attenuated in elderly (OR: 0.90; 95% CI: 0.17–5.42; p interaction = 0.03) and very elderly (OR: 0.36; 95% CI: 0.11–3.21; p interaction = 0.03). Interpretation: The effect of EVT appears significantly diminished among elderly patients in a public healthcare system in a developing country. Further studies are needed to understand the mechanism underlying these findings and properly assess the efficacy of EVT in this vulnerable population. ANN NEUROL 2026;100:644–652

  • Clinical characteristics and outcomes of SARS-CoV-2-associated stroke: a large multicenter national cohort study

    by João Brainer Clares de Andrade, Vinícius Viana Abreu Montanaro, Mayara Silva Marques, Kristel Larisa Back Merida, Rafaela Almeida Alquéres, Felipe Aydar Sandoval, Millene Rodrigues Camilo, Ahmad Ali El Madjdoub, Letícia Januzi de Almeida Rocha, Vinícius Luiz Cristofolini, et al.

  • Brain Frailty Rather than Age Alone Mediates the Lack of Benefit for Endovascular Thrombectomy in the Elderly Population of the RESILIENT Trial

    by Rui Kleber Do Vale Martins‐Filho, Thiago Oscar Goulart, Octavio Marques Pontes‐Neto, Fabricio O. Lima, Leticia C. Rebello, Mario B. Faria, Francisco Mont'ALverne, Bruno S. M. Parente, Leonardo A. Carbonera, Millene Rodrigues Camilo, et al.

    Objective: The objective of this study was to determine whether baseline computed tomography (CT) markers of cerebral small vessel disease (cSVD), as a surrogate of brain frailty, explain the association between age and functional outcome, potentially accounting for the reduced apparent benefit of mechanical thrombectomy (MT) in elderly patients in the RESILIENT trial. Methods: RESILIENT was a multicenter, prospective, randomized, open‐label trial with blinded outcome assessment conducted in Brazil. Patients with anterior circulation large‐vessel occlusion stroke were randomized to MT plus guideline‐based care or guideline‐based care alone, including intravenous alteplase when eligible. A vascular neurologist blinded to clinical data evaluated baseline CT scans for cSVD markers (leukoaraiosis, lacunes, and atrophy) to derive a composite cSVD score. Multivariable logistic regression identified independent predictors of good functional outcome (modified Rankin Scale [mRS] = 0–2 at 90 days). Treatment effects were assessed across subgroups defined by age (p < 0.01). No benefit was observed in older patients or in those with cSVD > 1. Mediation analysis showed that cSVD significantly mediated the association between age and outcome (average causal mediation effect [ACME] = –0.003, 95% CI = –0.005 to 0.00, p = 0.010). Interpretation: Baseline CT markers of cSVD were independently associated with poorer outcomes and mediated the association between age and functional outcome in the RESILIENT trial, potentially explaining the lack of MT efficacy in older patients. ANN NEUROL 2026


  • Open Access

    Reply to: “Management of transient ischemic attack in low- and middle-income country: a critical analysis”

    by Samia Talise El Horr de Moraes, Maramelia Miranda-Alves, Leticia Rebello, Sheila O. Martins, Fabricio Oliveira Lima, Wagner Mauad Avelar, Rodrigo Bazan, Marcos C. Lange

  • Open Access

    Transient ischemic attack in the practice of neurology in a low- and middle-income country

    by Samia Talise El Horr de Moraes, Maramelia Miranda-Alves, Leticia Rebello, Sheila O. Martins, Fabricio Oliveira Lima, Wagner Mauad Avelar, Rodrigo Bazan, Marcos C. Lange

    Transient ischemic attack (TIA) is a critical vascular event that often precedes strokes. Despite its significance, management varies widely across physicians.To evaluate the knowledge and practices of Brazilian physicians regarding TIA diagnosis and management.A survey was conducted among members of the Brazilian Academy of Neurology. It included questions about demographic information, TIA management practices, and knowledge of guidelines.While most respondents were neurologists or residents, there was significant variability in hospital admission, diagnostic testing, and treatment strategies. Many physicians relied on risk stratification tools but did not consistently follow guidelines for diagnostic imaging or medication.These findings highlight the need for improved education and standardized protocols for TIA management in Brazil. Implementing public health policies to address these gaps could significantly reduce stroke recurrence rates and improve patient outcomes.


  • Open Access

    The Music Within: A Doppler Harmonic Pattern Report in Non-Subarachnoid Hemorrhage Related Cerebral Vasospasm

    by Alessandra Braga Cruz Guedes de Morais, George Nilton Nunes Mendes, Ana Silvia Sobreira Lima Verde, Adson Freitas de Lucena, Francisco José Arruda Mont’aLverne, Fabricio Oliveira Lima, Fernanda Martins Maia Carvalho

    A 40-year-old male presented an episode of severe thunderclap headache with right hemiparesis. Imaging revealed severe stenosis in the left middle cerebral artery, associated with increased mean velocities detected by Transcranial Doppler Ultrasound (TCD). Notably, a distinctive "tin whistle" sound, known as a doppler harmonic effect, near the highest velocity point was observed during the examination. Extensive workup was performed, including CSF analysis and laboratory investigations, and the diagnosis of Reversible Cerebral Vasoconstriction Syndrome (RCVS) was established. Treatment involving medication and daily monitoring led to a decline in the left MCA's velocity, enabling the patient's discharge with no recurrent headaches or neurological deficits. Notably, a follow-up MRI exhibited the disappearance of the left MCA stenosis. This report discusses the rare occurrence of "musical murmurs" in cerebrovascular diseases, underscoring the potential for early diagnosis using techniques like TCD in emergency settings, particularly in conditions like RCVs.

  • Open Access

    Accuracy of predictive scores of hemorrhagic transformation in patients with acute ischemic stroke

    by João Brainer Clares de Andrade, Jay Preston Mohr, Muhammad Ahmad, Fabricio Oliveira Lima, Levi Coelho Maia Barros, Gisele Sampaio Silva

    Background: Hemorrhagic transformation (HT) is a complication in ischemic strokes, regardless of use of reperfusion therapy (RT). There are many predictive scores for estimating the risk of HT. However, most of them include patients also treated with RT. Therefore, this may lead to a misinterpretation of the risk of HT in patients who did not undergo RT. Objective: We aimed to review published predictive scores and analyze their accuracy in our dataset. Methods: We analyzed the accuracy of seven scales. Our dataset was derived from a cohort of 1,565 consecutive patients from 2015 to 2017 who were admitted to a comprehensive stroke center. All patients were evaluated with follow-up neuroimaging within seven days. Comparison of area under the curve (AUC) was performed on each scale, to analyze differences between patients treated with recombinant tissue plasminogen activator (tPA) and those without this treatment. Results: Our dataset provided enough data to assess seven scales, among which six were used among patients with and without tPA treatment. HAT (AUC 0.76), HTI (0.73) and SEDAN (0.70) were the most accurate scores for patients not treated with tPA. SPAN-100 (0.55) had the worst accuracy in both groups. Three of these scores had different cutoffs between study groups. Conclusions: The predictive scores had moderate to fair accuracy for predicting HT in patients treated with tPA. Three scales were more accurate for predicting HT in patients not treated with tPA. Through standardizing these characteristics and including more patients not treated with RT in a large multicenter series, accurate predictive scores may be created.


  • Abstract 14: Global Impact of the Covid-19 Pandemic on Subarachnoid Hemorrhage

    by Thanh N Nguyen, Diogo C Haussen, Muhammad M Qureshi, Hiroshi Yamagami, Toshiyuki Fujinaka, Ossama Y Mansour, Mohamad AbdalKader, Michael R Frankel, Zhongming Qiu, Allan Taylor, et al.

    Introduction: During the COVID-19 pandemic, decreased volumes of stroke admissions and mechanical thrombectomy were reported. The objective was to examine whether subarachnoid hemorrhage(SAH) hospitalizations and ruptured aneurysm coiling interventions demonstrated similar declines. Methods: We conducted a global, retrospective, observational study across 6 continents, 37 countries, and 140 comprehensive stroke centers. Patients with diagnosis of SAH, ruptured aneurysm coiling interventions, COVID-19 were identified using ICD-10 codes or by prospectively maintained stroke databases. The 3-month cumulative volume, monthly volumes for SAH hospitalizations and ruptured aneurysm coiling procedures were compared for the period before (1-year and immediately before) and during the COVID-19 pandemic (March 1 to May 31, 2020). Results: There was a significant decline in SAH hospitalizations with 2,044 admissions in the 3 months immediately before and 1,585 admissions during the pandemic, representing a decline of 22.5% (95%CI, -24.3 to -20.7, pConclusions: There was a global decrease in subarachnoid hemorrhage admissions and ruptured aneurysm embolizations during the COVID-19 pandemic. Among low-volume coiling SAH hospitals, there was an increase in the ruptured aneurysm coiling intervention. These findings in SAH are consistent with a global decrease in other emergencies such as stroke and myocardial infarction.*On behalf of the SVIN COVID-19 Collaborators